FLI1 and neoplasm: Several groups have already shown that circulating tumor cells (CTCs) carrying EWS–FLI1/ERG fusion transcripts may be detected in 6–43 % of the peripheral blood (PB) specimens of ES patients at the time of diagnosis but the prognostic significance of these findings remains disputable [4, 5, 31–35].